Trials / Completed
CompletedNCT07015645
Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 137 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess long-term outcomes of hypopituitarism following gamma knife radiosurgery (GKRS) for pituitary adenomas.
Detailed description
Pituitary adenomas (PAs) are one of the most common intracranial neoplasms, accounting for 10-20% of diagnosed brain tumors. Initial gamma knife radiosurgery (GKRS) can be an alternative treatment for selected NFPA patients with comorbidities, documented growth small tumors, cavernous sinus invasion, or advanced age. Hypopituitarism is one of the most common complications of radiosurgery (Cordeiro et al., 2018). Long-term follow-up is crucial to assess new pituitary deficits. Typically, hypopituitarism presents within the first 2-4 years after the treatment with radiosurgery, but the risk of pituitary insufficiency increases to up to 80%. Reports on the highest incidence of new-onset hypopituitarism also mentioned the longest follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Gamma Knife Radiosurgery | Patients received gamma knife radiosurgery (GKRS) treatment for pituitary adenomas. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2025-06-11
- Last updated
- 2025-06-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07015645. Inclusion in this directory is not an endorsement.